• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: February 20-24


ICYMI, this week we had stories about hidradenitis suppurativa coverage at Winter Clinical Miami, an NDA submission for roflumilast foam, an overview of the 2023 Biosimilars Report from Cardinal Health, and more.

Andrea Murina, MD, on Optimizing Your Therapy for Patients With Hidradenitis Suppurativa

From topical antibiotics like clindamycin to biologic injectables like adalimumab to surgical options like deroofing, treatment for HS can come in many forms.

Study Examines Dupilumab Effectiveness in Erythrodermic Atopic Dermatitis

Research published in JAMA Dermatology finds dupilumab works quickly and safely for patients with erythrodermic atopic dermatitis.

Renata Block, PA-C, Discusses Physical and Mental Wellbeing

It’s crucial for patients and health care providers to consider their personal wellbeing in their daily lives.

The Human Microbiota and Skin Cancer

Recent research highlighted the important role of the skin’s microbiota in maintaining the homeostasis of the skin and the potential role the human microbiota may play in the development of skin cancer.

Arcutis Submits NDA for Roflumilast Foam for the Treatment of Seborrheic Dermatitis

Adolescents and adults with seborrheic dermatitis may have a new topical treatment soon.

Vitiligo in Different Ethnicities

Clinicians should strive to address the unique medical and aesthetic challenges seen in vitiligo.

Will Kirby, DO, FAOCD, Talks With Blossom Hashemi, MSN, BS, FNP-C

Will Kirby, DO, FAOCD, talks with Blossom Hashemi, MSN, BS, FNP-C, about the best aesthetic career advice, available resources, and the role of allied health care professionals in aesthetics.

Bruce Feinberg, DO, Discusses 2023 Biosimilars Report From Cardinal Health

Biosimilars have been a trending topic in 2023 with 8 adalimumab biosimilars expected to hit the market this year.

Methotrexate may be Linked to Higher Risk of Skin Cancers

The drug used to treat several dermatological disorders has immunosuppressive effects and has been linked with photosensitizing properties.

Treating Atopic Dermatitis in the Winter: Moisturizers, Ointments and Creams

Patients suffering from atopic dermatitis may suffer more during the cold, dry winter month. Bernard Cohen, MD, professor of pediatrics and dermatology at Johns Hopkins University School of Medicine in Baltimore, Maryland, explores various treatment options that will add moisture back into the skin during seasonal flare-ups.

How Heavy Traffic Can Increase the Risk of Atopic Dermatitis

Researchers link proximity to heavy traffic and risk of atopic dermatitis in new study.

POLL: What Skin Condition is Caused by Poxvirus?

Click here to answer this week's poll.

The Mainstream Patient: February 23

This week's edition of the Mainstream Patient features stories about treating dry eyelids, face masks for acne-prone skin, acne scar treatments, and more.

Eczema Prevalence Varies by Race and Ethnicity, With Overall Increase Seen

Investigators compared these outcomes due to limited research in the space, with previous surveys suggesting care disparities.

Popular Haircare Brand Sued by Customers for Hair Loss

A lawsuit, filed by 28 plaintiffs in California, seeks a collective $75,000 in damages.

Pointers With Portela: Finding an Acne Skin Care Routine at Target

In this week’s Pointers with Dr Portela, the 208SkinDoc shows how to find an ideal and affordable acne skin care routine.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.